Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Planned sale EVP, General Counsel, Corp Sec sold 3,750 shares at an average $11.18 ($41,939)
  2. 4 Grant or award Director acquired 12,731 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Other disposition Director disposed of 8,000 shares (other)
  6. 4 Grant or award Director acquired 16,000 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Planned sale Director sold 3,200 shares at $9.45 ($30,240)
  9. 4 Planned sale SVP, Chief Accounting Officer sold 379 shares at $9.45 ($3,582)
  10. 4 Grant or award Director acquired 8,000 shares (grant or award)
  11. 4 Grant or award Director acquired 8,000 shares (grant or award)
  12. 4 Grant or award Director acquired 8,000 shares (grant or award)
  13. 4 Grant or award Director acquired 8,000 shares (grant or award)
  14. 4 Grant or award Director acquired 8,000 shares (grant or award)
  15. 4 Grant or award Director acquired 8,000 shares (grant or award)
  16. 4 Planned sale Director sold 22,000 shares at $10.05 ($221,025)
  17. 4 Other disposition President and CEO disposed of 233,532 shares (other)
  18. 4 Planned sale President and CEO sold 72,559 shares at $9.16 ($664,350)
  19. 4 Planned sale Director sold 22,000 shares at $9.07 ($199,617)
  20. 4 Planned sale SVP, Chief Accounting Officer sold 7,711 shares at $9.12 ($70,324)

Page 1 of 25 · 489 filings